Company news
Milestone Pharmaceuticals Inc. news in 2020
Milestone Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.
Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT
November 17, 2020
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
November 12, 2020
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
October 22, 2020
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
September 21, 2020
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update
August 11, 2020
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
July 22, 2020
Milestone Pharmaceuticals Announces $25 Million Private Placement
July 22, 2020
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update
May 13, 2020
Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
March 22, 2020
Milestone Pharmaceuticals Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Clinical and Corporate Update
March 5, 2020
Decks in 2020
- Technical Presentation (May 2020)
Technical · 17 slides · May 1, 2020
- Corporate Update (March 2020)
Corporate update · 16 slides · Mar 23, 2020